Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Yes Sir Captain!!!
I’m your copilot!
AltaCorp Capital
MediPharm Labs Corp. (LABS-T) is poised to benefit from the "gradual" shift from dried flower to cannabis extract products, especially with expected legalization of derivative products in what is being dubbed Cannabis 2.0, said AltaCorp Capital analyst David Kideckel.
He initiated coverage of the Barrie, Ont.-based cannabis extraction services provider with an "outperform" rating.
"LABS focuses on private label and white label services," he said. "In our view, these are attractive high-margin and high-growth product segments that expose the Company to a wide range of products and clients. Further, we believe LABS' focus on these segments will allow it to differentiate itself and leverage its capabilities underpinned by technology, expertise, and scale.
"Our bullish view on LABS is supported by the Company's execution and international growth opportunities. To date, LABS has secured several private label and white label agreements, including for export into Australia and Germany. Pending licensing conditions, LABS can utilize its Australian facility as an export hub into Asia-Pacific, and its Canadian facility for export into Europe, Latin America, the Caribbean, and Africa. As the cannabis regulatory outlook improves in different jurisdictions and the international cannabis industry matures, we view LABS' footprint and expansion strategy as key to achieving its long-term success."
Mr. Kideckel said MediPharm's early profitability "validates" its business strategy, noting it possesses the largest trailing 12-month revenue among its peers.
"The Company also achieved positive adjusted EBITDA and operating cash flow before working capital changes over the last two quarters," the analyst said. "In our view, these results demonstrate the Company's early successes in the still-nascent cannabis industry and validate its execution and business strategy to date."
"The first European deal for Canadian firm MediPharm Labs will see its medical cannabis products made available to 20,000 German pharmacies."
I think $LABS is just waiting on EU GMP certification now. MEDIF
https://www.google.com/amp/s/cbdtesters.co/2019/10/05/20000-german-pharmacies-to-stock-canadian-firms-cannabis-medipharm/amp/
Shorters and fear mongers about vapes..... holding and hoping for a squeeze soon
Drop some pr news Monday am...squeeze the mf’ers
Too many day traders bought in at lows
DATE SET FOR Q3 EARNINGS: Financial results for the 3 & 9 months ended Sept 30, 2019 will be released before markets open on Tuesday, Nov 12, 2019, in advance of the Company’s TSX issuer reporting deadline.
Remember in the old days of posting CHOO, CHOO
Giddy up, to the moon.....
Me neither
Hey deswag you on Twitter for a PM
SECOND, LARGER SHIPMENT TO AUSTRALIA: MediPharm Labs Increases Exports of Medical Cannabis Concentrate to Australia; second shipment volume increased 137%, now landed downunder. #medicalcannabis #global
Anybody sell??
MADD, What’s your vibe on Nasdaq? It’s the next logical step I agree ...hmmm
Good to hear! : ) I’m honestly excited with their expansion and things to come. I’m ok blocking the noise and being patient here
yep and until confirmation by health Canada what the vape plan is most likely more downside. I didn’t pull the plug soon enough so I’m stuck riding the waves. I’m long LABS anyhow
Shake my head
AUSTRALIA MEDIA INTERVIEW: Senior Project Manager - Australia, James Lee is interviewed onsite by the local Gippsland Channel 9 TV station, sharing an update of our facility build
bit.ly/2nhRxNO
This sector is sooo beat down, nothing saving it for awhile that I see. It’s a freakin joke that every stock is held down. Riding the waves cause I’m long here just shaking my head, WTF
$LABS PI Financial "Bumping 2020E Revenue"
PT Raised from C$8.75 to C$9 with BUY rating.
$LABS:
NR past 5 trading days:
Australia deal and LOI’s
Private label vape manufacturing deal with $CRON
Organic certification
First European Private label deal with ADREXpharma in Germany (20,000 pharmacies)
$27 million private label deal with $TER ($192 mil potential over 36 months)
Crazy....what is insane is that some longs from way back on this board are preaching sell on social media lol . Not many I’m long on but LABS is one
$9.10 now ....WTF
Makes sense, LABS not if but when for sure!!!
Hey Merc, what do you think holds up EUGMP CERTIFICATION? Is it the buildout of capacity? I know VGW has been waiting also, wonder who gets it first....VGW is under construction too..... thoughts anyone
WOW.
MediPharm Labs and TerrAscend Enter Major Private Label Concentrate Supply Agreement With Potential Value Up to $192 Million
Is it China, the Impeachment, or bullshit Vape issue???
Bunch of quick fingers this morning... good morning all!!
lol, I’m great at multitasking and damn iPhone.,...too easy ya know??? Anyhow, yes we know what we own just a waiting game. Funny thing, use to own Roku stock sold for a 10k gain at around $30 usd what a f&@king idiot look where it went too .....lol
MediPharm Labs Receives Organic Certification for Cannabis Oil and Extracts for Medical- and Adult-Use Markets
This if f&$king hilarious, day in and day out in this sector. Wish o could not look at this stock for a 6 months but being the crackhead that I am ain’t happening, another day of driving me bonkers....good opening and flushed again
$LABS $MEDIF. What’s great is the amount of product to fulfill this with Cronos being a company with international production and distribution across five continents. Not a small play!!!! streetinsider.com/dr/news.php?id…
MediPharm to produce high-quality cannabis concentrate filled vapes for Cronos Group
· Deal reinforces MediPharm Labs’ leadership in large scale manufacturing and distribution
Boom.
MediPharm Labs and Cronos Group Enter Private Label Contract Manufacturing Agreement
For those who missed the Town Hall meeting / video recording, the key takeaways in my opinion are:
a bunch of new contracts about to hit .. imho
also sounds like there looking for 3rd facility
for their global expansion, serious about growing and spreading their Business model internationally!
and really looking like we might hear a pharma ingredient deal in the future
Sorry the question marks were a 100 percent sign that came up as those question marks
?? agreed, ill ride the roller coaster, the gains will come : )